Thursday, May 08, 2025 7:13:51 AM
💥TODAYS BREAKING CBD RESEARCH NEWS💥
https://www.frontiersin.orghttps//www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1528520/abstract
“CBD promotes anti tumor activity by modulating tumor immune micro environment in HPV associated Head and Neck Squamous Cell Carcinoma.”
https://www.marijuanamoment.net/psychedelic-therapy-can-help-reduce-problematic-alcohol-and-tobacco-use-scientific-review-shows/
“CBD may also have the potential to treat substance use disorders involving cocaine, amphetamine and methamphetamine adding to earlier research showing the cannabinoid has the potential to help people battling substance abuse use disorders involving alcohol and opioids.”
“Unfortunate for the board trolls 🧌, short minds and competitors who are lost.”
https://www.frontiersin.orghttps//www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1528520/abstract
“CBD promotes anti tumor activity by modulating tumor immune micro environment in HPV associated Head and Neck Squamous Cell Carcinoma.”
https://www.marijuanamoment.net/psychedelic-therapy-can-help-reduce-problematic-alcohol-and-tobacco-use-scientific-review-shows/
“CBD may also have the potential to treat substance use disorders involving cocaine, amphetamine and methamphetamine adding to earlier research showing the cannabinoid has the potential to help people battling substance abuse use disorders involving alcohol and opioids.”
“Unfortunate for the board trolls 🧌, short minds and competitors who are lost.”
Bullish
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
